Ceribell System with Clarity®
Detection of Non-Convulsive Seizures & Status Epilepticus
FDA ClearedCommercial
Key Facts
Indication
Detection of Non-Convulsive Seizures & Status Epilepticus
Phase
FDA Cleared
Status
Commercial
Company
About Ceribell
Ceribell is a private medical device company headquartered in Sunnyvale, California, focused on transforming the diagnosis and management of patients with serious neurological conditions. Its core technology is a portable, rapidly deployable EEG platform combined with sophisticated AI algorithms, most notably the Clarity® seizure detection algorithm. The company has achieved significant clinical validation with over 135 publications, FDA clearances for neonates through adults, and demonstrated impact on reducing ICU length of stay and improving patient outcomes.
View full company profile